Gene therapy for brain tumors
- 1 October 2000
- journal article
- review article
- Published by Springer Nature in Current Oncology Reports
- Vol. 2 (5) , 463-472
- https://doi.org/10.1007/s11912-000-0067-z
Abstract
"Gene therapy" can be defined as the transfer of genetic material into a patient's cells for therapeutic purposes. To date, a diverse and creative assortment of treatment strategies utilizing gene therapy have been devised, including gene transfer for modulating the immune system, enzyme prodrug ("suicide gene") therapy, oncolytic therapy, replacement/therapeutic gene transfer, and antisense therapy. For malignant glioma, gene-directed prodrug therapy using the herpes simplex virus thymidine kinase gene was the first gene therapy attempted clinically. A variety of different strategies have now been pursued experimentally and in clinical trials. Although, to date, gene therapy for brain tumors has been found to be reasonably safe, concerns still exist regarding issues related to viral delivery, transduction efficiency, potential pathologic response of the brain, and treatment efficacy. Improved viral vectors are being sought, and potential use of gene therapy in combination with other treatments is being investigated.Keywords
This publication has 72 references indexed in Scilit:
- Adenovirus-mediated p53 Gene Therapy for Human GliomasNeurosurgery, 1999
- Vaccine therapy for cancerfact or fiction?QJM: An International Journal of Medicine, 1999
- p53 and Brain Tumors: From Gene Mutations to Gene TherapyBrain Pathology, 1998
- Adenoviral delivery of B7–1 (CD80) increases the immunogenicity of human ovarian and cervical carcinoma cellsGene Therapy, 1998
- Bystander Effect-Mediated Therapy of Experimental Brain Tumor by Genetically Engineered Tumor CellsHuman Gene Therapy, 1998
- Adeno-associated Virus Vector Containing the Herpes Simplex Virus Thymidine Kinase Gene Causes Complete Regression of Intracerebrally Implanted Human Gliomas in Mice, in Conjunction with Ganciclovir AdministrationJapanese Journal of Cancer Research, 1998
- Topical Review: Gene Therapy for Neurologic Disease: Benchtop Discoveries to Bedside Applications. 2. The BedsideJournal of Child Neurology, 1997
- Urokinase Antisense Oligodeoxynucleotides as a Novel Therapeutic Agent for Malignant Glioma:In Vitroandin VivoStudies of Uptake, Effects and ToxicityBiochemical and Biophysical Research Communications, 1996
- Direct gene transfer of a plasmid carrying the Herpes Simplex Virus-thymidine kinase gene (HSV-TK) in transplanted murine melanoma: In vivo studyEuropean Journal Of Cancer, 1996
- Antisense Oligonucleotides for Central Nervous System TumorsNeurosurgery, 1996